Showing 5921-5930 of 20432 results for "".
- Deep Brain Stimulation and Exercise: A Paradigm Shift in Parkinson's Managementhttps://reachmd.com/news/deep-brain-stimulation-and-exercise-a-paradigm-shift-in-parkinsons-management/2474878/With tremors and rigidity often persisting despite optimized pharmacotherapy, Parkinson’s disease treatment continues to fall short, prompting exploration of deep brain stimulation as a promising approach for improving motor function.
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://reachmd.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2474873/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more than thre
- Predictive Analytics in Neurosurgery: Revolutionizing Postoperative Monitoringhttps://reachmd.com/news/predictive-analytics-in-neurosurgery-revolutionizing-postoperative-monitoring/2474890/Recent validation studies demonstrate that predictive analytics, such as a tailored prediction score for elective craniotomies, can reduce unplanned ICU admissions and
- ADA: Dermatologists Need to Lead on Climate Healthhttps://reachmd.com/news/ada-dermatologists-need-to-lead-on-climate-health/2474867/The American Dermatological Association (ADA) has issued its first comprehensive policy statement on climate change, publishing the document in the Journal of Investigative Dermatology.
- Revance Announces CEO Transitionhttps://reachmd.com/news/revance-announces-ceo-transition/2475370/Revance announced a leadership transition last week as part of a long-term succession strategy following its integration with Crown Laboratories, according to a news release from the company. Founder and CEO of Crown Laboratories Jeff Bedard will assume the role of Executive Chai
- Hypoxia: A Crucial Target in Colon Cancer's Tumor Microenvironmenthttps://reachmd.com/news/hypoxia-a-crucial-target-in-colon-cancers-tumor-microenvironment/2474862/Clinicians face an urgent need to dissect colon cancer’s tumor microenvironment more precisely, as hypoxia emerges not as an incidental byproduct but as a pivotal driver of invasive tumor growth and resistance to standard therapies such as FO
- Machine Learning and Metabolic Profiling in Colorectal Cancer Diagnosticshttps://reachmd.com/news/machine-learning-and-metabolic-profiling-in-colorectal-cancer-diagnostics/2474855/By harnessing the nuanced insights of metabolic profiling, which focuses on the chemical processes within cells, and metabolomic profiling, which specifically analyses the metabolites present, machine learning is redefining the precision of c
- Assessment and De-Labeling of False Penicillin Allergies in Community Pharmacy Settingshttps://reachmd.com/news/assessment-and-de-labeling-of-false-penicillin-allergies-in-community-pharmacy-settings/2474840/Researchers at Monash University have developed an algorithm set to transform antibiotic stewardship by precisely identifying and de-labeling false penicillin allergies in community pharmacies. This algorithm effectively differentiates true allergic re
- Exploring Obesity Risk Genetics and the Gut Microbiomehttps://reachmd.com/news/exploring-obesity-risk-genetics-and-the-gut-microbiome/2474842/Obesity management remains challenging as both inherited and microbial factors intricately shape energy balance. Recent data compiled in Gut bacteria and genes jointly shape obesity risk reveal that genetic predispositions intersect with microbial ecosystems to modulate fat storage and
- At-Home LED Devices and Acne Vulgaris Managementhttps://reachmd.com/news/at-home-led-devices-and-their-role-in-acne-vulgaris-management/2474847/Acne vulgaris presents a considerable challenge in dermatology, impacting patients' lives significantly. Recent systematic reviews reveal that at-home LED treatments achieve a reduction of 45.3% in inflammatory lesions and 47.7% in non-inflammatory les